ATXS vs RHI · rev $706.0K vs P/E 21, rev $5.38B
Astria Therapeutics Inc (ATXS) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
ATXS currently screens at market cap $382.1M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the ATXS and RHI stock pages for the full models.
Not investment advice.